Precision BioSciences Inc (NASDAQ:DTIL)

1.74
Delayed Data
As of May 19
 -0.05 / -2.81%
Today’s Change
1.49
Today|||52-Week Range
14.38
-76.49%
Year-to-Date
Caribou Charges Ahead on Study Results
May 17 / GuruFocus News - Paid Partner Content
Precision BioSciences (DTIL) Reports Q1 Loss, Misses Revenue Estimates
May 09 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close1.78
Today’s open1.75
Day’s range1.68 - 1.81
Volume553,914
Average volume (3 months)671,417
Market cap$98.9M
Data as of 4:03pm ET, 05/19/2022

Growth & Valuation

Earnings growth (last year)+75.11%
Earnings growth (this year)-242.73%
Earnings growth (next 5 years)--
Revenue growth (last year)+375.72%
P/E ratioNM
Price/Sales3.76
Price/Book1.06

Competitors

----
VBLTVascular Biogenics L...-0.02-1.27%
SURFSurface Oncology Inc-0.01-0.51%
LPTXLeap Therapeutics In...-0.01-0.82%
Data as of 4:03pm ET, 05/19/2022

Financials

Next reporting dateAugust 18, 2022
EPS forecast (this quarter)-$0.44
Annual revenue (last year)$115.5M
Annual profit (last year)-$30.6M
Net profit margin-26.49%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
Durham, North Carolina

Forecasts